Renovia receives FDA clearance for leva(R) Pelvic Health System as first-line treatment for chronic fecal incontinence

Clearance for new indication follows FDA Breakthrough Device Designation BOSTON, July 7, 2022 -- (Healthcare Sales & Marketing Network) -- Renovia Inc. ("Renovia"), a developer of non-surgical, treatments for female pelvic floor disorders and... Devices, FDA Renovia , leva Pelvic Health, fecal incontinence
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news